BIOTRANSFORMATION OF PRAVASTATIN SODIUM(I) - MECHANISMS OF ENZYMATIC TRANSFORMATION AND EPIMERIZATION OF AN ALLYLIC HYDROXY GROUP OF PRAVASTATIN SODIUM

被引:37
作者
KITAZAWA, E
TAMURA, N
IWABUCHI, H
UCHIYAMA, M
MURAMATSU, S
TAKAHAGI, H
TANAKA, M
机构
[1] Analytical and Metabolic Research Laboratories, Sankyo Co., Ltd., Shinagawa-ku, Tokyo 140, 2-58
关键词
D O I
10.1006/bbrc.1993.1457
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
One of the major metabolites, R-416(3′α-OH), of pravastatin sodium(PV, 6′β-OH), and a minor metabolite, R-418(6′α-OH), were produced in rat liver cytosol in the presence of adenosine 3′-phosphate 5′-phosphosulfate as a cofactor. The reactions were inhibited by the inhibitors for sulfotransferases, and 18OH was introduced to the 3′α- and 6′α-positions of R-416 and R-418, respectively, by incubation with H2 18O. These results strongly suggested that PV was metabolically activated by sulfation at the 6′β-hydroxy group by sulfotransferases, followed by nucleophilic attack of hydroxy anions at the 3′α- or 6′α-position, to give R-416 or R-418, respectively. © 1993 Academic Press.
引用
收藏
页码:597 / 602
页数:6
相关论文
共 13 条
  • [1] ARAI M, 1988, ANN REP SANKYO RES L, V40, P1
  • [2] EVERETT DW, 1991, DRUG METAB DISPOS, V19, P740
  • [3] TISSUE SELECTIVITY OF PRAVASTATIN SODIUM, LOVASTATIN AND SIMVASTATIN - THE RELATIONSHIP BETWEEN INHIBITION OF DENOVO STEROL SYNTHESIS AND ACTIVE-DRUG CONCENTRATIONS IN THE LIVER, SPLEEN AND TESTIS IN RAT
    KOGA, T
    FUKUDA, K
    SHIMADA, Y
    FUKAMI, M
    KOIKE, H
    TSUJITA, Y
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 209 (01): : 315 - 319
  • [4] CARRIER-MEDIATED UPTAKE OF PRAVASTATIN BY RAT HEPATOCYTES IN PRIMARY CULTURE
    KOMAI, T
    SHIGEHARA, E
    TOKUI, T
    KOGA, T
    ISHIGAMI, M
    KUROIWA, C
    HORIUCHI, S
    [J]. BIOCHEMICAL PHARMACOLOGY, 1992, 43 (04) : 667 - 670
  • [5] METABOLISM OF PRAVASTATIN SODIUM IN ISOLATED RAT HEPATOCYTES .1. GLUTATHIONE CONJUGATE FORMATION REACTION
    MURAMATSU, S
    MIYAGUCHI, K
    IWABUCHI, H
    MATSUSHITA, Y
    NAKAMURA, T
    KINOSHITA, T
    TANAKA, M
    TAKAHAGI, H
    [J]. XENOBIOTICA, 1992, 22 (05) : 487 - 498
  • [6] A HYDROXYMETHYL SULFATE ESTER AS AN ACTIVE METABOLITE OF THE CARCINOGEN, 5-HYDROXYMETHYLCHRYSENE
    OKUDA, H
    HIRATSUKA, A
    NOJIMA, H
    WATABE, T
    [J]. BIOCHEMICAL PHARMACOLOGY, 1986, 35 (03) : 535 - 538
  • [7] Sasahara K., 1988, J CLIN THER MED, V4, P45
  • [8] 6-ALPHA-HYDROXY-ISO-ML-236B (6-ALPHA-HYDROXY-ISO-COMPACTIN) AND ML-236A, MICROBIAL TRANSFORMATION PRODUCTS OF ML-236B
    SERIZAWA, N
    NAKAGAWA, K
    TSUJITA, Y
    TERAHARA, A
    KUWANO, H
    TANAKA, M
    [J]. JOURNAL OF ANTIBIOTICS, 1983, 36 (07) : 918 - 920
  • [9] HEPATIC DNA AND RNA ADDUCT FORMATION FROM THE CARCINOGEN 7-HYDROXYMETHYL-12-METHYLBENZ[A]ANTHRACENE AND ITS ELECTROPHILIC SULFURIC-ACID ESTER METABOLITE IN PREWEANLING RATS AND MICE
    SURH, YJ
    LAI, CC
    MILLER, JA
    MILLER, EC
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 144 (02) : 576 - 582
  • [10] CS-514, A COMPETITIVE INHIBITOR OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE - TISSUE-SELECTIVE INHIBITION OF STEROL SYNTHESIS AND HYPOLIPIDEMIC EFFECT ON VARIOUS ANIMAL SPECIES
    TSUJITA, Y
    KURODA, M
    SHIMADA, Y
    TANZAWA, K
    ARAI, M
    KANEKO, I
    TANAKA, M
    MASUDA, H
    TARUMI, C
    WATANABE, Y
    FUJII, S
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 877 (01) : 50 - 60